These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12197622)

  • 1. Study of interaction of gastrointestinal agents in the presence of cytoprotective drugs. Part II. In vitro study on the adsorption of selected spasmolytic drugs on sucralfate.
    Pluta J; Grimling B
    Acta Pol Pharm; 2001; 58(6):473-9. PubMed ID: 12197622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on interaction of gastrointestinal agents in the presence of cytoprotective drugs. Part III. In vitro study on the adsorption of selected prokinetic drugs on sucralfate.
    Grimling B; Pluta J
    Acta Pol Pharm; 2005; 62(1):69-73. PubMed ID: 16022497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of interaction of gastroenterological agents in the presence of cytoprotective drugs. Part I: Adsorption of the chosen inhibitors of histamine H2 receptors on sucralfat in vitro.
    Grimling B; Pluta J
    Acta Pol Pharm; 2000; 57(3):239-44. PubMed ID: 11143714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro investigation of sodium diclofenac adsorption on sucralfate.
    Grimling B; Pluta J
    Acta Pol Pharm; 2006; 63(6):515-20. PubMed ID: 17438869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interaction between papaverine hydrochloride and antacids].
    Mielcarek J; Sapór J
    Acta Pol Pharm; 1992; 49(5-6):23-6. PubMed ID: 16092195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of sucralfate in gastrointestinal diseases.
    Candelli M; Carloni E; Armuzzi A; Cammarota G; Ojetti V; Pignataro G; Santoliquido A; Pola R; Pola E; Gasbarrini G; Gasbarrini A
    Panminerva Med; 2000 Mar; 42(1):55-9. PubMed ID: 11019606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of sucralfate tablets vs. suspension on oral doxycycline absorption in dogs.
    KuKanich K; KuKanich B
    J Vet Pharmacol Ther; 2015 Apr; 38(2):169-73. PubMed ID: 25233871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part I).
    Lauritsen K; Laursen LS; Rask-Madsen J
    Clin Pharmacokinet; 1990 Jul; 19(1):11-31. PubMed ID: 1974182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of sucralfate with antibiotics used for selective decontamination of the gastrointestinal tract.
    Feron B; Adair CG; Gorman SP; McClurg B
    Am J Hosp Pharm; 1993 Dec; 50(12):2550-3. PubMed ID: 8122691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of prostatitis treatment secondary to probable ciprofloxacin-sucralfate drug interaction.
    Spivey JM; Cummings DM; Pierson NR
    Pharmacotherapy; 1996; 16(2):314-6. PubMed ID: 8820479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress ulcer prophylaxis in patients on ventilator.
    Darlong V; Jayalakhsmi TS; Kaul HL; Tandon R
    Trop Gastroenterol; 2003; 24(3):124-8. PubMed ID: 14978984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sucralfate (Ulcogant). Mechanism of action of a cytoprotective agent].
    Steiner KF
    Fortschr Med; 1983 Dec; 101(46):2153-6 contd. PubMed ID: 6689310
    [No Abstract]   [Full Text] [Related]  

  • 13. Sucralfate, a basic aluminum salt of sucrose sulfate. IV. Interaction with enzyme pepsin.
    Yoshida N; Terao N; Nagashima R
    Arzneimittelforschung; 1980; 30(1):78-80. PubMed ID: 6768370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate.
    Krueger WA; Ruckdeschel G; Unertl K
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1725-30. PubMed ID: 9257749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Drug-Drug Pharmacokinetic Interaction Potential of Sucralfate with Other Drugs: Review and Perspectives.
    Sulochana SP; Syed M; Chandrasekar DV; Mullangi R; Srinivas NR
    Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):469-503. PubMed ID: 27086359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characteristics of sucralfate.
    Nagashima R
    J Clin Gastroenterol; 1981; 3(Suppl 2):103-10. PubMed ID: 6798099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sucralfate and bezoars: data from the system of pharmacologic vigilance and review of the literature].
    Guy C; Ollagnier M
    Therapie; 1999; 54(1):55-8. PubMed ID: 10216423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucralfate therapy in NSAID bleeding gastropathy.
    Malagelada JR; Rodríguez de la Serna A; Dammann HG; Pons M; Armas C; Sala M; Tena X; Celdrán E; Mesa A
    Clin Gastroenterol Hepatol; 2003 Jan; 1(1):51-6. PubMed ID: 15017517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative mucoretention of sucralfate suspensions in an everted rat esophagus model.
    Dobrozsi DJ; Smith RL; Sakr AA
    Int J Pharm; 1999 Oct; 189(1):81-9. PubMed ID: 10518688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of residual water content on the physico-chemical properties of sucralfate dried gel obtained by microwave drying.
    Gainotti A; Losi E; Bettini R; Colombo P; Sonvico F; Baroni D; Santi P; Colombo G
    Drug Dev Ind Pharm; 2005 Aug; 31(7):645-52. PubMed ID: 16207612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.